EXTH-57. HIGH CONTENT SCREENING OF PATIENT-DERIVED CELL LINES HIGHLIGHTS THE POTENTIAL OF NON-STANDARD CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA
Jessica Taylor(University of Manchester), Brian Bigger(University of Manchester), Brian A. Telfer(University of Manchester), Kenny Yu(Memorial Sloan Kettering Cancer Center), Ian Peers(AstraZeneca (United Kingdom)), Kaye J. Williams(University of Manchester), Joanna Dutko-Gwóźdź, Gareth Griffiths(NIHR Evaluation Trials and Studies Coordinating Centre), Deniz Beyit, Omar Pathmanaban(Manchester Academic Health Science Centre), Ian Kamaly-Asl(Royal Manchester Children's Hospital), Peter Ceuppens, Rod Benson, Catherine McBain(Unknown)
Cited by 0
Related Papers
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
|The Lancet|2007|570